HKBU-led research team develops novel anti-viral targeted drug for nasopharyngeal cancer treatment
A research team led by Hong Kong Baptist University (HKBU) has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein produced by EBV, leading to the shrinkage of tumours caused by the virus. It is the first...
New HKBU-led study unveils COVID-19 transmission patterns and safety-conscious reopening plans
With the COVID-19 pandemic resulting in lockdowns in different parts of the world, from the US to many European nations, there have been intense debates on when and how we can safely reopen the economy. New research led by HKBU computer...
Staff Publications and Presentations (October 2014)
31 Oct 2014
Staff Publications and Presentations (September 2014)
30 Sep 2014
Staff Publications and Presentations (August 2014)
29 Aug 2014
Clinical study finds Chinese medicine treatment of chronic gastritis has efficacy rate of nearly 90% in blocking gastric precancerous lesions
21 Aug 2014
Chinese medicine scholar develops novel nano-vesicles for controlled release of medication for pulmonary diseases via inhalation
18 Aug 2014
Staff Publications and Presentations (July 2014)
31 Jul 2014